0001415889-22-006751.txt : 20220617
0001415889-22-006751.hdr.sgml : 20220617
20220617164538
ACCESSION NUMBER: 0001415889-22-006751
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220616
FILED AS OF DATE: 20220617
DATE AS OF CHANGE: 20220617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PERRY GREGORY D
CENTRAL INDEX KEY: 0001236371
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38150
FILM NUMBER: 221024590
MAIL ADDRESS:
STREET 1: C/O IMMUNOGEN, INC.
STREET 2: 830 WINTER ST.
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kala Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001479419
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 270604595
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1167 MASSACHUSETTS AVENUE
CITY: ARLINGTON
STATE: MA
ZIP: 02476
BUSINESS PHONE: 781-996-5252
MAIL ADDRESS:
STREET 1: 1167 MASSACHUSETTS AVENUE
CITY: ARLINGTON
STATE: MA
ZIP: 02476
4
1
form4-06172022_040613.xml
X0306
4
2022-06-16
0001479419
Kala Pharmaceuticals, Inc.
KALA
0001236371
PERRY GREGORY D
C/O KALA PHARMACEUTICALS, INC.
1167 MASSACHUSETTS AVENUE
ARLINGTON
MA
02476
true
false
false
false
Stock Option (right to buy)
0.36
2022-06-16
4
A
0
40000
0
A
2032-06-15
Common Stock
40000
40000
D
This option was granted on June 16, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 16, 2023 or (ii) the date of the first annual meeting following June 16, 2022.
/s/ Mary Reumuth, Attorney-in-Fact
2022-06-17